Release Date: 31/07/17 10:02 Summary: Appendix 4C - June 2017 Quarterly Statement of Cash Flows Price Sensitive: Yes Download Document 288.11KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status